Capricor Therapeutics (CAPR) PT Lowered to $3.50 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Capricor Therapeutics (NASDAQ: CAPR) to $3.50 (from $8.60) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
